Dihydrosyringin

Details

Top
Internal ID c35065bf-e418-42a9-8944-66c545f42bd2
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Glycosyl compounds > Phenolic glycosides
IUPAC Name (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-(3-hydroxypropyl)-2,6-dimethoxyphenoxy]oxane-3,4,5-triol
SMILES (Canonical) COC1=CC(=CC(=C1OC2C(C(C(C(O2)CO)O)O)O)OC)CCCO
SMILES (Isomeric) COC1=CC(=CC(=C1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)OC)CCCO
InChI InChI=1S/C17H26O9/c1-23-10-6-9(4-3-5-18)7-11(24-2)16(10)26-17-15(22)14(21)13(20)12(8-19)25-17/h6-7,12-15,17-22H,3-5,8H2,1-2H3/t12-,13-,14+,15-,17+/m1/s1
InChI Key NBCWSGSBMHILQP-GAGVYUBLSA-N
Popularity 3 references in papers

Physical and Chemical Properties

Top
Molecular Formula C17H26O9
Molecular Weight 374.40 g/mol
Exact Mass 374.15768240 g/mol
Topological Polar Surface Area (TPSA) 138.00 Ų
XlogP -1.10
Atomic LogP (AlogP) -1.19
H-Bond Acceptor 9
H-Bond Donor 5
Rotatable Bonds 8

Synonyms

Top
CHEMBL2332681

2D Structure

Top
2D Structure of Dihydrosyringin

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.7810 78.10%
Caco-2 - 0.7415 74.15%
Blood Brain Barrier - 0.5750 57.50%
Human oral bioavailability - 0.6286 62.86%
Subcellular localzation Mitochondria 0.6748 67.48%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8543 85.43%
OATP1B3 inhibitior + 0.9546 95.46%
MATE1 inhibitior - 0.9000 90.00%
OCT2 inhibitior - 0.8250 82.50%
BSEP inhibitior - 0.5742 57.42%
P-glycoprotein inhibitior - 0.8188 81.88%
P-glycoprotein substrate - 0.8186 81.86%
CYP3A4 substrate + 0.5687 56.87%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7653 76.53%
CYP3A4 inhibition - 0.9196 91.96%
CYP2C9 inhibition - 0.8320 83.20%
CYP2C19 inhibition - 0.9069 90.69%
CYP2D6 inhibition - 0.9132 91.32%
CYP1A2 inhibition - 0.8452 84.52%
CYP2C8 inhibition + 0.6035 60.35%
CYP inhibitory promiscuity - 0.8645 86.45%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9500 95.00%
Carcinogenicity (trinary) Non-required 0.7258 72.58%
Eye corrosion - 0.9893 98.93%
Eye irritation - 0.9662 96.62%
Skin irritation - 0.8123 81.23%
Skin corrosion - 0.9518 95.18%
Ames mutagenesis - 0.7400 74.00%
Human Ether-a-go-go-Related Gene inhibition - 0.3748 37.48%
Micronuclear - 0.7141 71.41%
Hepatotoxicity - 0.8447 84.47%
skin sensitisation - 0.8547 85.47%
Respiratory toxicity - 0.5222 52.22%
Reproductive toxicity + 0.5778 57.78%
Mitochondrial toxicity - 0.5750 57.50%
Nephrotoxicity - 0.7910 79.10%
Acute Oral Toxicity (c) III 0.8103 81.03%
Estrogen receptor binding - 0.5954 59.54%
Androgen receptor binding - 0.6340 63.40%
Thyroid receptor binding + 0.6123 61.23%
Glucocorticoid receptor binding + 0.6561 65.61%
Aromatase binding - 0.6226 62.26%
PPAR gamma + 0.6623 66.23%
Honey bee toxicity - 0.8504 85.04%
Biodegradation - 0.6500 65.00%
Crustacea aquatic toxicity - 0.7804 78.04%
Fish aquatic toxicity - 0.7914 79.14%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.60% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 95.92% 91.11%
CHEMBL3060 Q9Y345 Glycine transporter 2 94.73% 99.17%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 92.60% 85.14%
CHEMBL2581 P07339 Cathepsin D 90.68% 98.95%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 89.83% 86.92%
CHEMBL1293249 Q13887 Kruppel-like factor 5 89.25% 86.33%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 89.15% 95.89%
CHEMBL3401 O75469 Pregnane X receptor 84.45% 94.73%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 84.19% 94.00%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 80.99% 96.00%
CHEMBL226 P30542 Adenosine A1 receptor 80.74% 95.93%

Cross-Links

Top
PubChem 71720642
NPASS NPC215833
LOTUS LTS0266178
wikiData Q104392797